UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008552 |
|---|---|
| Receipt number | R000009961 |
| Scientific Title | A single-blind randomized controlled trial comparing Aprepitant plus (Granisetron)1st 5-HT3 receptor antagonist and Palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapies including CBDCA in the gynecology cancer patients. |
| Date of disclosure of the study information | 2012/08/01 |
| Last modified on | 2021/08/03 17:37:40 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/07/27 19:35:18 | ||
| 2 | Update | 2013/03/19 20:25:53 | Recruitment status |
|
| 3 | Update | 2013/03/19 20:28:19 | Recruitment status |
|
| 4 | Update | 2013/03/20 08:14:36 | Public title |
|
| 5 | Update | 2013/03/20 08:16:12 | Condition |
|
| 6 | Update | 2014/01/29 19:45:26 | TEL |
|
| 7 | Update | 2015/09/09 07:38:25 | Randomization unit |
|
| 8 | Update | 2016/07/31 17:20:55 | Name of primary person or sponsor Organization |
|
| 9 | Update | 2017/01/30 11:31:27 | Recruitment status |
|
| 10 | Update | 2020/02/01 13:58:35 | Date of IRB Last follow-up date |
|
| 11 | Update | 2021/08/03 17:34:36 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Tel1 Organization Organization Address Address Tel |
|
| 12 | Update | 2021/08/03 17:37:40 | Recruitment status |
